PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
CPHI
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Safeguarding your IP: Thermo Fisher Scientific Pharma Services’ Global Commitment to Confidentiality

Intellectual property (IP) rights and confidentiality protections play a critical role in biopharmaceutical development and manufacturing. Appropriate protections enable developers to drive innovation, safeguard investments, and accelerate the development of new drugs and therapies, while creating
a favourable environment for research, development, and commercialisation. Partnering with a CDMO with the global expertise to navigate complex landscape requirements, and with global frameworks in place to standardise protections, can alleviate potential challenges for drug developers and IP
owners.

At Thermo Fisher Scientific, we are committed to keeping your intellectual property and confidential information secure. We understand the sensitivity of your data and apply the same rigorous controls as we do to our own information. We standardise these strict controls across all sites in our global network to help ensure your information is safe, regardless of where you work with us.

Enforcing Contractual Protections

Our standard contractual terms are consistent with industry expectations and allow customers to legally enforce our confidentiality and IP obligations.

Confidentiality Protections

  • Strict processes ensure a valid CDA is in place prior to and
    throughout the disclosure of confidential information
  • Confidentiality obligations are incorporated in the MSA and
    apply throughout the project and afterwards
  • All pharma services sites have rigorous standards in
    handling confidential information conforming to Thermo
    Fisher Scientific global policies

IP ownership

  • Customer information disclosed to us remains the property
    of the customer at all times
  • New customer IP under the MSA is assigned to customer
    across all our sites and in compliance with local laws
  • Employee agreements, including affiliates subcontractors,
    are consistent with our IP obligations towards the customer
  • We offer technical support as requested by the customer
    in securing new customer IP (e.g. assistance with patent
    applications)

Protecting Your Data
We implement Thermo Fisher Scientific corporate best practices across all pharma services sites to keep your data safe and secure.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC

Thanks for reading International Biopharmaceutical Industry.

Fill the from to continue reading.